Learn how we’re changing the world of medicine. Discover career opportunities, our product pipeline, and browse media resources. Meet Moderna.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease–human metapneumovirus (hMPV virus) and parainfluenza virus.

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Our Mindsets Alongside our Values, our Mindsets allow us to overcome challenges together. We are working to build the best possible version of Moderna 20 years from now. These Mindsets are tools …

Nov 20, 2025 · Piper Sandler's 37th Annual Healthcare Conference Webcast > November 20, 2025 Moderna's Analyst Day Webcast > VIEW ALL EVENTS Page of 26

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Learn more about Spikevax® (COVID-19 Vaccine, mRNA) 2025-2026 Formula, Moderna's updated COVID-19 vaccine for individuals aged 12+. For US healthcare providers.

In addition to mRNA vaccines, Moderna is working on other applications of potential mRNA therapeutics that could help people with cancer, metabolic diseases and more.

Resources for journalists and media members. The latest press releases by Moderna.

Find contact information, important phone numbers and addresses to Moderna head.